Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | 44,030 | reported | 28 Feb 2020 | tx 18+254,073−2,800 |
| Ohr Pharmaceutical Inc | 37,600 | reported | 09 Sept 2022 | tx 11+362,659 |
| Gain Therapeutics, Inc. | 15,000 | reported | 24 Jun 2025 | tx 13+511,782−54,900 |
| Lev Pharmaceuticals Inc | 0 | reported | 15 Feb 2007 | tx 5+150,000−375,000 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
| Altimmune, Inc. |
| 0 |
| reported |
| 22 Nov 2016 |
| tx 68+3,175,441−1,564,532 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Jun 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Jul 2024 | PURCHASE | Gain Therapeutics, Inc. | 5,000 | 1.23 USD | |
| 01 Jul 2024 | PURCHASE | Gain Therapeutics, Inc. | 12,000 | 1.21 USD | first after silence |
| 24 Jun 2024 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 20 Sept 2023 | EXERCISE | Gain Therapeutics, Inc. | 54,900 | — | |
| 20 Sept 2023 | EXERCISE | Gain Therapeutics, Inc. | 54,900 | 0.00 USD | deriv |
| 20 Sept 2022 | GRANT_AWARD | Gain Therapeutics, Inc. | 54,900 | 0.00 USD | deriv |
| 20 Sept 2022 | GRANT_AWARD | Gain Therapeutics, Inc. | 329,400 | 0.00 USD | deriv |
| 09 Sept 2022 | GRANT_AWARD | Ohr Pharmaceutical Inc | 37,600 | 0.00 USD | deriv |
| 25 May 2022 | PURCHASE | Gain Therapeutics, Inc. | 2,482 | 2.58 USD | |
| 19 May 2022 | PURCHASE | Gain Therapeutics, Inc. | 4,000 | 2.71 USD | |
| 20 May 2022 | PURCHASE | Gain Therapeutics, Inc. | 9,256 | 2.83 USD | |
| 03 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 1,300 | 1.72 USD | |
| 01 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 1,580 | 1.58 USD | |
| 04 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 1,000 | 1.62 USD | |
| 19 Aug 2021 | GRANT_AWARD | Ohr Pharmaceutical Inc | 38,135 | 0.00 USD | deriv |
| 16 Aug 2021 | EXERCISE | Gain Therapeutics, Inc. | 4,922 | 7.87 USD | |
| 26 Apr 2021 | PURCHASE | Ohr Pharmaceutical Inc | 5,000 | 5.00 USD | |
| 09 Sept 2020 | GRANT_AWARD | Ohr Pharmaceutical Inc | 14,634 | 0.00 USD | deriv |
| 30 Apr 2020 | PURCHASE | Ohr Pharmaceutical Inc | 8,333 | 6.00 USD | |
| 30 Apr 2020 | PURCHASE | Ohr Pharmaceutical Inc | 2,500 | 6.00 USD | first after silence |
| 28 Feb 2020 | GRANT_AWARD | ADMA BIOLOGICS, INC. | 7,500 | 0.00 USD | |
| 28 Feb 2020 | GRANT_AWARD | ADMA BIOLOGICS, INC. | 15,000 | 0.00 USD | deriv |
| 12 Jul 2019 | GRANT_AWARD | Ohr Pharmaceutical Inc | 25,247 | — | |
| 12 Jul 2019 | GRANT_AWARD | Ohr Pharmaceutical Inc | 227,330 | 0.00 USD | deriv |
6 purchases reported after at least 12 months of silence — most recent on 01 Jul 2024.